# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-25-026371
Filing Date
2025-03-31
Accepted
2025-03-31 17:00:42
Documents
89
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ANNUAL REPORT | ea0232395-10k_actinium.htm iXBRL | 10-K | 1516777
2 | CONSENT OF MARCUM LLP | ea023239501ex23-1_actinium.htm | EX-23.1 | 1872
3 | CERTIFICATION | ea023239501ex31-1_actinium.htm | EX-31.1 | 10385
4 | CERTIFICATION | ea023239501ex31-2_actinium.htm | EX-31.2 | 10893
5 | CERTIFICATION | ea023239501ex32-1_actinium.htm | EX-32.1 | 5009
6 | CERTIFICATION | ea023239501ex32-2_actinium.htm | EX-32.2 | 5036
12 | GRAPHIC | image_001.jpg | GRAPHIC | 134660
13 | GRAPHIC | image_002.jpg | GRAPHIC | 14170
14 | GRAPHIC | image_003.jpg | GRAPHIC | 9451
15 | GRAPHIC | image_004.jpg | GRAPHIC | 16912
16 | GRAPHIC | image_005.jpg | GRAPHIC | 11984
17 | GRAPHIC | image_006.jpg | GRAPHIC | 14141
18 | GRAPHIC | image_006a.jpg | GRAPHIC | 14262
19 | GRAPHIC | image_006b.jpg | GRAPHIC | 21622
20 | GRAPHIC | image_007.jpg | GRAPHIC | 22814
21 | GRAPHIC | image_008.jpg | GRAPHIC | 7763
22 | GRAPHIC | image_009.jpg | GRAPHIC | 12568
23 | GRAPHIC | image_010.jpg | GRAPHIC | 18033
24 | GRAPHIC | image_011.jpg | GRAPHIC | 14843
25 | GRAPHIC | image_012.jpg | GRAPHIC | 21213
26 | GRAPHIC | image_013.jpg | GRAPHIC | 14579
27 | GRAPHIC | image_014.jpg | GRAPHIC | 9789
28 | GRAPHIC | image_015.jpg | GRAPHIC | 19038
29 | GRAPHIC | image_016.jpg | GRAPHIC | 14527
30 | GRAPHIC | image_017.jpg | GRAPHIC | 14367
31 | GRAPHIC | image_018.jpg | GRAPHIC | 12673
32 | GRAPHIC | image_019.jpg | GRAPHIC | 20843
33 | GRAPHIC | image_020.jpg | GRAPHIC | 21396
34 | GRAPHIC | image_021.jpg | GRAPHIC | 20995
35 | GRAPHIC | image_022.jpg | GRAPHIC | 3637
| Complete submission text file | 0001213900-25-026371.txt |  | 6759713

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL SCHEMA FILE | atnm-20241231.xsd | EX-101.SCH | 36506
8 | XBRL CALCULATION FILE | atnm-20241231_cal.xml | EX-101.CAL | 39621
9 | XBRL DEFINITION FILE | atnm-20241231_def.xml | EX-101.DEF | 195271
10 | XBRL LABEL FILE | atnm-20241231_lab.xml | EX-101.LAB | 422066
11 | XBRL PRESENTATION FILE | atnm-20241231_pre.xml | EX-101.PRE | 220894
91 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0232395-10k_actinium_htm.xml | XML | 444765

Mailing Address 100 PARK AVE., 23RD FLOOR NEW YORK NY 10017
Business Address 100 PARK AVE., 23RD FLOOR NEW YORK NY 10017 (646) 677-3870
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36374 | Film No.: 25794642
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)